| # | Drug | Count |
|---|---|---|
| 0 | RISDIPLAM | 12 |
| 1 | METHOTREXATE SODIUM | 6 |
| 2 | ABATACEPT | 5 |
| 3 | METHOTREXATE | 5 |
| 4 | SPIRONOLACTONE | 5 |
| 5 | MELOXICAM | 4 |
| 6 | RITUXIMAB | 4 |
| 7 | SODIUM OXYBATE | 4 |
| 8 | CARVEDILOL | 3 |
| 9 | FUROSEMIDE | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | METHOHEXITAL SODIUM | 1 | 0.0079 |
| 1 | RISDIPLAM | 12 | 0.0029 |
| 2 | CHLOROTHIAZIDE SODIUM | 1 | 0.0011 |
| 3 | CHLOROTHIAZIDE | 1 | 0.0008 |
| 4 | SENNA LAXATIVE | 1 | 0.0008 |
| 5 | CLOMIPHENE CITRATE | 1 | 0.0007 |
| 6 | RITUXIMAB-ABBS | 3 | 0.0006 |
| 7 | ESTRADIOL/NORETHINDRONE ACETATE | 1 | 0.0005 |
| 8 | SUCCINYLCHOLINE CHLORIDE | 1 | 0.0004 |
| 9 | CAFFEINE CITRATE | 1 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Survival of Motor Neuron 2 Splicing Modifier [EPC] | 12 | 0.0029 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 2 | Dopamine and Norepinephrine Reuptake Inhibitor [EPC] | 1 | 0.0003 |
| 3 | Antifibrinolytic Agent [EPC] | 1 | 0.0001 |
| 4 | Melatonin Receptor Agonist [EPC] | 1 | 0.0001 |
| 5 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |
| 6 | Vasopressin V2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 7 | Nonergot Dopamine Agonist [EPC] | 1 | 0.0001 |
| 8 | Sympathomimetic-like Agent [EPC] | 2 | 0.0001 |
| 9 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |